Close



Nov 21, 2023 01:53PM
Mar 13, 2023 07:00AM
Dec 28, 2022 07:01AM
Dec 28, 2022 07:00AM
Dec 8, 2022 07:00AM
Nov 25, 2022 07:00AM
Nov 2, 2022 07:15AM Can-Fite: Positive New Data from it’s Phase III Psoriasis Study will be Presented Today at an Industry Expert Summit in Boston
Oct 25, 2022 07:00AM
Oct 13, 2022 07:00AM
Sep 12, 2022 07:00AM
Aug 25, 2022 07:00AM
Aug 23, 2022 07:00AM
Aug 22, 2022 07:00AM
Aug 17, 2022 07:26AM Can-Fite BioPharma (CANF) Reports Progress in the Development of Piclidenoson for Osteoarthritis in Pets Through its Partner Vetbiolix
Aug 17, 2022 07:25AM
Jul 11, 2022 07:01AM
Jul 11, 2022 07:00AM
Jun 29, 2022 07:00AM
Jun 24, 2022 07:00AM
Jun 9, 2022 07:01AM
Jun 9, 2022 07:00AM Can-Fite Announces Publication of Clinical Study Data for Piclidenoson and Namodenoson in Scientific Journal
May 26, 2022 07:00AM
May 16, 2022 07:00AM
May 2, 2022 07:00AM
Apr 5, 2022 07:00AM
Mar 28, 2022 07:00AM
Mar 14, 2022 07:02AM
Mar 14, 2022 07:00AM Can-Fite: Namodenoson’s Treatment of Liver Fibrosis Receives Notice of Allowance from U.S. Patent Office
Mar 11, 2022 07:00AM
Mar 8, 2022 07:00AM
Jan 31, 2022 07:00AM
Jan 13, 2022 07:00AM
Jan 10, 2022 07:26AM
Jan 5, 2022 07:00AM
Dec 29, 2021 07:00AM Following Complete Clearance of Cancer Lesions in Advanced Liver Cancer Patient, Can-Fite is Filing Patent Applications for the Treatment of Various Advanced Solid Tumors
Dec 20, 2021 04:05PM
Dec 20, 2021 07:04AM
Dec 20, 2021 07:00AM
Dec 7, 2021 07:06AM
Dec 7, 2021 07:00AM
Nov 26, 2021 07:00AM
Nov 24, 2021 07:00AM Can-Fite CEO Dr. Pnina Fishman to be Guest Speaker at 5th Annual NASH Summit 2021
Nov 23, 2021 07:00AM
Nov 12, 2021 07:00AM
Nov 1, 2021 07:01AM
Nov 1, 2021 07:00AM
Oct 28, 2021 07:22AM
Oct 28, 2021 07:00AM
Oct 26, 2021 07:00AM Can-Fite CEO to Present Namodenoson’s Clinical Trial Data as Expert Speaker at 5th Annual Antifibrotic Drug Development Summit
Oct 21, 2021 07:00AM

251,657 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All